Miotrol Tablet 2.5 mg contains Zolmitriptan, a selective serotonin (5-HT1B/1D) receptor agonist, used for the acute treatment of migraine attacks with or without aura. It is not intended for the prevention of migraines but provides rapid relief from headache, nausea, photophobia, and other associated symptoms during an acute episode. Zolmitriptan works by narrowing dilated blood vessels in the brain and reducing neurogenic inflammation, which helps alleviate migraine pain and associated discomfort.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Zolmitriptan 2.5 mg per tablet

Indications

Miotrol Tablet 2.5 mg is indicated for:

• Acute treatment of migraine attacks in adults

• Relief of migraine-associated symptoms such as nausea, vomiting, and sensitivity to light and sound

• Treatment of migraines with or without aura

It is most effective when taken at the onset of a migraine attack. Miotrol is not intended for the prophylactic management of migraine.

Mechanism of Action

Zolmitriptan is a selective agonist for serotonin 5-HT1B and 5-HT1D receptors located on cranial blood vessels and sensory nerves. Its mechanism includes:

• Vasoconstriction: Narrows dilated intracranial arteries to reduce migraine pain.

• Inhibition of neuropeptide release: Reduces the release of vasoactive neuropeptides involved in migraine pathophysiology.

• Modulation of pain pathways: Diminishes transmission of pain signals in the trigeminal nerve system.

This targeted action provides rapid and effective relief from migraine symptoms without causing significant systemic effects.

Dosage and Administration

• The recommended starting dose is 2.5 mg orally, taken as a single tablet at the onset of migraine symptoms.

• If the migraine persists, a second dose may be taken after 2 hours, with a maximum of 2 doses in 24 hours.

• Tablets should be swallowed whole with water and can be taken with or without food.

• Not recommended for use in children under 12 years or in elderly patients without medical supervision.

Always follow your healthcare provider’s instructions for dosing, especially if you have cardiovascular risk factors.

Benefits

• Provides rapid relief from migraine headache

• Reduces associated symptoms such as nausea, vomiting, and sensitivity to light and sound

• Effective for migraines with or without aura

• Convenient oral tablet formulation

• Improves quality of life during acute migraine episodes

Miotrol helps patients manage migraines effectively, allowing them to resume normal daily activities more quickly.

Precautions

• Contraindicated in patients with ischemic heart disease, uncontrolled hypertension, or history of stroke or TIA.

• Use cautiously in patients with liver or kidney impairment.

• Avoid use with other serotonergic drugs to prevent serotonin syndrome.

• Not recommended during pregnancy or breastfeeding without medical advice.

• Seek medical attention if severe chest pain, shortness of breath, or neurological symptoms occur after taking the tablet.

Possible Side Effects

Miotrol Tablet 2.5 mg is generally well tolerated. Common side effects may include:

• Dizziness or fatigue

• Flushing

• Nausea

• Tingling or numbness

• Rarely, chest discomfort or palpitations

Most side effects are mild and transient. Severe adverse reactions require immediate medical attention.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Zolmitriptan may interact with other triptans, MAO inhibitors, SSRIs, or SNRIs. Always inform your doctor of all medications and supplements being used.

Storage Instructions

• Store below 30°C in a dry, dark place.

• Keep the tablets in their original packaging to protect from moisture.

• Keep out of reach of children.

Conclusion

Miotrol Tablet 2.5 mg (Zolmitriptan) is an effective therapy for acute migraine attacks, providing rapid relief from headache and associated symptoms. Its selective action on serotonin receptors makes it a reliable option for adults suffering from migraines, improving quality of life when taken under proper medical supervision.